MS vs PAHC · P/E 20, rev $41.93B vs P/E 13, rev $1.52B
Morgan Stanley (MS) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MS revenue for 2026-06-30 was $41.93B. Net income was $11.15B. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the MS and PAHC stock pages for the full models.
Not investment advice.